by Team Small News | Jun 17, 2025 | Pfizer, Pharma
Pfizer has recently secured the global rights outside of China for 3SBio’s dual-target cancer therapy, SSGJ-707. This deal marks a significant collaboration between the two companies, with Pfizer gaining exclusive rights to develop, manufacture, and... by Team Small News | Jun 16, 2025 | Pfizer, Pharma
A US Food and Drug Administration (FDA) advisory panel has rejected Pfizer’s bid to expand the use of its breast cancer drug, Talzenna (talazoparib). The panel voted against approving the medication for use in patients with a type of breast cancer known as... by Team Small News | Jun 15, 2025 | Pfizer, Pharma
A US Food and Drug Administration (FDA) advisory panel has rejected Pfizer’s bid to expand the use of its drug Talzenna (talazoparib) to treat metastatic prostate cancer. The panel’s decision was based on the results of a clinical trial that failed to show... by Team Small News | Jun 8, 2025 | Pfizer, Pharma
Pfizer CEO Albert Bourla recently sat down with Reuters for an interview, where he discussed the crucial balance between driving innovation in the pharmaceutical industry and ensuring global access to medicines. Bourla emphasized the importance of finding a middle... by Team Small News | Jun 6, 2025 | Aurobindo Pharma, Pfizer, Pharma
The US Food and Drug Administration (FDA) has granted approval to Aurobindo Pharma for its varenicline tablets, available in 0.5 mg and 1 mg strengths. This approval marks a significant milestone for Aurobindo, as its varenicline tablets are the generic equivalent of... by Team Small News | Jun 4, 2025 | Pfizer, Pharma
The American Society of Clinical Oncology (ASCO) annual meeting was held in Chicago, featuring over 5,000 research abstracts on various cancer treatments and studies. Several pharmaceutical giants and biotech companies presented promising data, including AstraZeneca,...